Keyphrases
Liver Transplantation
55%
Immune Reconstitution
27%
Central Venous Line
27%
Central Line Placement
27%
Kidney Transplant Recipients
27%
Nonmyeloablative
27%
Induction Protocol
27%
Deceased Donor
27%
Hepatocellular Carcinoma
27%
Thrombotic Microangiopathy
27%
Extracorporeal Shock Wave Lithotripsy
27%
Negative Impact
27%
Acute Pyelonephritis
27%
Treatment Strategy
27%
Neutrophil-lymphocyte Ratio
27%
Simultaneous Liver Kidney
27%
Patient Survival
27%
Two-kidney
27%
Cynomolgus Macaque
27%
Cytomegalovirus Reactivation
27%
Filtration Effect
27%
Membrane Filtration
27%
Alginate Scaffold
27%
Portal Venous Gas
27%
Survival Outcomes
27%
Ultrasound-guided
27%
Bone Marrow Transplantation
27%
Tolerance Induction
27%
Chest X-ray
27%
Operating Room
27%
Cytomegalovirus Viremia
22%
Cytomegalovirus
22%
Viremia
22%
Exploratory Laparotomy
18%
Rapamycin
16%
Kidney Model
13%
MELD Score
13%
Pretransplant
13%
Islet Survival
13%
Allocation Policy
11%
Cyclosporine
11%
High Dose
11%
Affect Management
9%
Patient Management
9%
Impact on Patients
9%
Whipple Procedure
9%
Rare Complication
9%
Radiological Findings
9%
Malposition
9%
Portal Venous System
9%
Medicine and Dentistry
Kidney Graft
100%
Liver Transplantation
97%
Allograft
89%
Transplantation
40%
Kidney Allograft
38%
Graft Survival
37%
Microangiopathy
27%
Lymphocyte
27%
Diabetes
27%
Hepatocellular Carcinoma
27%
Extracorporeal Shock Wave Lithotripsy
27%
Chimera
27%
Diabetes Mellitus
27%
Exploratory Laparotomy
27%
Nonmyeloablative Conditioning
27%
Kidney Function
27%
Pyelonephritis
27%
Neutrophil
27%
Tricalcium Phosphate
27%
Tertiary Hyperparathyroidism
27%
Biopsy
17%
Immunosuppressive Treatment
13%
Sepsis
13%
Dihydrotetrabenazine
13%
Portal Venous System
13%
Liver Graft
9%
Model for End-Stage Liver Disease
9%
Cytotoxic T-Cell
9%
Cinacalcet
8%
Atypical Hemolytic Uremic Syndrome
7%
Hyaline Degeneration
6%
Heart Transplantation
6%
Graft Failure
6%
Hepatic Portal System
6%
Diabetic Nephropathy
6%
Kidney Transplantation
6%
Patient History of Transplantation
6%
Biopsy Technique
6%
Odds Ratio
6%
Model For End Stage Liver Disease Score
6%
Ischemia
6%
Retransplantation
5%
Perioperative Monitoring
5%
Disease Free Survival
5%
Immunology and Microbiology
Liver Transplantation
69%
Macaca fascicularis
60%
Chimera
55%
Allotransplantation
55%
Transplant Procedure
39%
Regulatory T Cell
37%
Conditioning
36%
Bone Marrow Transplantation
34%
Immune Reconstitution
32%
Mouse
31%
Lymphocyte
27%
Macrophage
27%
Cytomegalovirus
27%
Cell Division
27%
Insulin Resistance
27%
Neutrophil
27%
Kidney Function
27%
Immunosuppression
20%
Viremia
15%
T Cell
11%
Cytotoxic T-Cell
11%
Insulin Blood Level
9%
Glucose Blood Level
9%
Fat Pad
6%
Sirolimus
5%
Disease Free Survival
5%
